# Interparfums (IPAR) — Earnings

IPAR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ipar/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.95 |
| EPS estimate | $0.97 |
| EPS surprise | −2.06% |
| Revenue surprise | +0.00% |
| Revenue | $341.0M |
| Revenue estimate | $341.0M |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/822663/000175392626001317/ipar-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/62e85b0d-a60c-8a0a-d026-0371c95049e5.html) |

Interparfums reported Q2 2026 results on August 4, 2026. Earnings per share were $0.95, 2.06% below the $0.97 estimate. Revenue of $341.0 million matched the $341.0 million consensus. Compared with Q2 2025, EPS slipped about 4% from $0.99, while revenue rose about 2% from $333.9 million.

The table shows a clear seasonal pattern. Q3 is the strongest quarter each year, and Q3 2025 set the highs in the table at $2.05 per share and $429.6 million in revenue. Q4 is usually the weakest. Annual EPS climbed from $3.78 in 2022 to $4.75 in 2023, $5.16 in 2024 and $5.24 in 2025, a gain of about 39% over three years. The first half of 2026 totals $2.30, almost level with $2.31 a year earlier. Over the last 20 quarters, Interparfums beat EPS estimates 15 times and missed five. The only loss in the table was Q4 2021, at $0.04 per share.

Interparfums reported Q3 between November 5 and November 9 in each of the past five years. That points to early November 2026 for the next report. It will show whether the usual Q3 peak returns and how nine-month EPS compares with 2025.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | $0.97 | $0.95 | -2.06% | $341.0M | $341.0M |
| Q1 2026 | May 5, 2026 | $1.18 | $1.35 | 14.44% | $345.0M | $344.9M |
| Q4 2025 | Feb 24, 2026 | $0.78 | $0.88 | 12.75% | $386.0M | $386.2M |
| Q3 2025 | Nov 5, 2025 | $1.93 | $2.05 | 6.20% | $430.0M | $429.6M |
| Q2 2025 | Aug 5, 2025 | $1.08 | $0.99 | -8.08% | $334.0M | $333.9M |
| Q1 2025 | May 5, 2025 | $1.12 | $1.32 | 18.09% | $339.0M | $339.0M |
| Q4 2024 | Feb 25, 2025 | $0.80 | $0.82 | 3.03% | $362.0M | $361.5M |
| Q3 2024 | Nov 6, 2024 | $1.82 | $1.93 | 6.28% | $425.0M | $424.6M |
| Q2 2024 | Aug 6, 2024 | $1.05 | $1.14 | 8.54% | $342.0M | $342.2M |
| Q1 2024 | May 7, 2024 | $1.54 | $1.27 | -17.48% | $324.0M | $324.0M |
| Q4 2023 | Feb 27, 2024 | $0.35 | $0.32 | -9.58% | $329.0M | $328.7M |
| Q3 2023 | Nov 7, 2023 | $1.26 | $1.66 | 31.75% | $368.0M | $368.0M |
| Q2 2023 | Aug 8, 2023 | $0.90 | $1.09 | 20.64% | $309.0M | $309.2M |
| Q1 2023 | May 8, 2023 | $1.41 | $1.68 | 18.83% | $312.0M | $311.7M |
| Q4 2022 | Feb 28, 2023 | $0.29 | $0.52 | 80.06% | $311.0M | $310.8M |
| Q3 2022 | Nov 9, 2022 | $0.99 | $1.30 | 31.07% | $280.0M | $280.5M |
| Q2 2022 | Aug 9, 2022 | $0.98 | $0.86 | -11.89% | $244.7M | $244.7M |
| Q1 2022 | May 10, 2022 | $0.88 | $1.10 | 25.11% | $250.7M | $250.7M |
| Q4 2021 | Mar 1, 2022 | −$0.20 | −$0.04 | 80.01% | $210.8M | $210.7M |
| Q3 2021 | Nov 8, 2021 | $0.68 | $1.20 | 76.44% | $262.7M | $262.7M |

## Frequently Asked Questions

### When did Interparfums (IPAR) last report earnings?

Interparfums last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did IPAR beat earnings estimates?

No. Interparfums reported EPS of $0.95 for Q2 2026 against a $0.97 estimate — a 2.06% miss.

### How much revenue did IPAR report last quarter?

Interparfums reported $341.0M in revenue for Q2 2026, against a consensus estimate of $341.0M.

## Similar Stocks

- [ELF](https://www.lighthorse.io/tickers/elf) — e.l.f. Beauty, Inc. Common Stock
- [COTY](https://www.lighthorse.io/tickers/coty) — Coty Inc. Class A Common Stock
- [LW](https://www.lighthorse.io/tickers/lw) — Lamb Weston Holdings, Inc. Common Stock
- [NUS](https://www.lighthorse.io/tickers/nus) — Nu Skin Enterprises, Inc. Common Stock
- [POST](https://www.lighthorse.io/tickers/post) — Post Holdings, Inc. Common Stock
- [CELH](https://www.lighthorse.io/tickers/celh) — Celsius Holdings, Inc. - Common Stock
- [MED](https://www.lighthorse.io/tickers/med) — MEDIFAST INC Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).